Business Wire India

Reckitt and PATH-CHRI Announce Winners of Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator, Advancing India’s Journey Towards Viksit Bharat @2047

Brand Post · Oct 7, 2025

Reckitt and PATH-CHRI Announce Winners of Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator, Advancing India’s Journey Towards Viksit Bharat @2047

Brand Post · Oct 7, 2025

Praj Low-Carbon Solution to Drive Substantial Carbon Intensity Reduction at Aemetis California Ethanol Plant

Brand Post · Oct 7, 2025

Wipro Limited to Announce Results for the Second Quarter Ended September 30, 2025, on October 16, 2025

Brand Post · Oct 7, 2025

Protectt.ai Launches AI Security Platform at GFF 2025 to Mitigate Enterprise Agentic AI Risks

Brand Post · Oct 7, 2025

R Systems Recognized as a Leader in Everest Group’s Software Product Engineering Services for Mid-market Enterprises PEAK Matrix® Assessment 2025

Brand Post · Oct 7, 2025

Thales Launches Europe’s First Certified Smartcard Ready for the Quantum Age

Brand Post · Oct 7, 2025

TransUnion CIBIL Featured in Bharat Fintech Story, an Edstead Series Streaming on JioHotstar

Brand Post · Oct 7, 2025

Capital A Leverages Ant International’s AI-Enabled FX Solution to Optimise Treasury Operations and Enhance Customer Experience

Brand Post · Oct 7, 2025

SG Entertech Expands Snack VR to Southeast Asia, Seeking Local Partners

Brand Post · Oct 7, 2025

Gramiyaa Redefines Cooking Oil Category with India’s First Freshness Focused Gable-Top Pack

Brand Post · Oct 7, 2025

Motorola Launches Moto g06 POWER with Segment’s Largest 7000mAh Battery, 6.88″ 120Hz Display, Dolby Atmos, and 50MP Camera at Rs. 7,499

Brand Post · Oct 7, 2025

Kitsault Energy Proposes Bold Initiative for Canada’s Economic Prosperity and India’s Energy Security

Brand Post · Oct 7, 2025

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

Brand Post · Oct 7, 2025

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

Brand Post · Oct 7, 2025

Business

Stock Market

Finance

Tech

Sports

Entertainment

Sectors

Lifestyle

More

Latest Articles by Business Wire India

Reckitt and PATH-CHRI Announce Winners of Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator, Advancing India’s Journey Towards Viksit Bharat @2047

Reckitt and PATH-CHRI Announce Winners of Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator, Advancing India’s Journey Towards Viksit Bharat @2047

Praj Low-Carbon Solution to Drive Substantial Carbon Intensity Reduction at Aemetis California Ethanol Plant

Wipro Limited to Announce Results for the Second Quarter Ended September 30, 2025, on October 16, 2025

Protectt.ai Launches AI Security Platform at GFF 2025 to Mitigate Enterprise Agentic AI Risks

R Systems Recognized as a Leader in Everest Group’s Software Product Engineering Services for Mid-market Enterprises PEAK Matrix® Assessment 2025

Thales Launches Europe’s First Certified Smartcard Ready for the Quantum Age

TransUnion CIBIL Featured in Bharat Fintech Story, an Edstead Series Streaming on JioHotstar

Capital A Leverages Ant International’s AI-Enabled FX Solution to Optimise Treasury Operations and Enhance Customer Experience

SG Entertech Expands Snack VR to Southeast Asia, Seeking Local Partners

Gramiyaa Redefines Cooking Oil Category with India’s First Freshness Focused Gable-Top Pack

Motorola Launches Moto g06 POWER with Segment’s Largest 7000mAh Battery, 6.88″ 120Hz Display, Dolby Atmos, and 50MP Camera at Rs. 7,499

Kitsault Energy Proposes Bold Initiative for Canada’s Economic Prosperity and India’s Energy Security

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones